Comparative Benchmarking
In the context of the broader market, HOWL competes directly with industry leaders such as SDEV and ATNM. With a market capitalization of $33.05M, it holds a significant position in the sector. When comparing efficiency, HOWL's gross margin of N/A stands against SDEV's N/A and ATNM's N/A. Such benchmarking helps identify whether Werewolf Therapeutics Inc is trading at a premium or discount relative to its financial performance.
